Next 10 |
home / stock / bct:cc / bct:cc news
Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MD Two poster presentations include Drs. Hurvitz (Fred Hutchinson Cancer Center), Brufsky (UPMC), and Cristofanilli (Weill Cornell) as authors PHILADELPHIA and VANCOUVER, British Columb...
Preclinical data shows that BriaCell’s Bria-OTS+™ and Bria-PROS+™ effectively induce an anti-cancer immune response via multiple mechanisms including naïve helper and killer T cells, dendritic cells, and natural killer (NK) cells The novel mechanisms of actio...
PFS of 4.2 months in Phase 2 ADC resistant patients receiving Bria-IMT™ pivotal Phase 3 formulation is twice that of controls in similar studies PFS results reinforced by larger number of prior treatments in Bria-IMT™ population than in comparable studies Bri...
A look at the top 10 most actives in Canada TC Energy Corporation (TRP) fell 1.1% to $54.04 on volume of 26,244,209 shares Calibre Mining Corp. (CXB) fell 7.2% to $1.68 on volume of 26,036,155 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 3.1% to $3.78 on volume of 12,240...
A look at the top 10 most actives in Canada Canadian Natural Resources Limited (CNQ) rose 1.1% to $99.36 on volume of 15,927,514 shares Crescent Point Energy Corp. (CPG) rose 1.0% to $10.62 on volume of 11,545,321 shares Global Atomic Corporation (GLO) fell 30.7% to $2.17 on volume of 11,...
A look at the top 10 most actives in Canada Lundin Mining Corporation (LUN) fell 0.1% to $12.7 on volume of 10,285,870 shares Canadian Natural Resources Limited (CNQ) fell 0.6% to $99.01 on volume of 6,570,639 shares TC Energy Corporation (TRP) fell 1.0% to $54.51 on volume of 4,227,716 s...
A look at the top 10 most actives in Canada Cenovus Energy Inc. (CVE) fell 0.0% to $24.15 on volume of 11,784,891 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 13.4% to $4.15 on volume of 11,675,241 shares Bitfarms Ltd. (BITF) fell 6.4% to $3.36 on volume of 9,646,374 sha...
Agreement with a leading cancer treatment group to advance the clinical development of Bria-OTS+ (breast cancer) and Bria-PROS+ (prostate cancer), BriaCell’s novel off-the-shelf personalized cancer vaccines, marks a major milestone for BriaCell PHILADELPHIA and VANCOUVER, British...
PHILADELPHIA and VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer c...
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies t...
News, Short Squeeze, Breakout and More Instantly...
Briacell Therapeutics Corp. Company Name:
BCT:CC Stock Symbol:
TSXC Market:
Oral presentation by Mayo Clinic Professor and Principal Investigator, Saranya Chumsri, MD Two poster presentations include Drs. Hurvitz (Fred Hutchinson Cancer Center), Brufsky (UPMC), and Cristofanilli (Weill Cornell) as authors PHILADELPHIA and VANCOUVER, British Columb...
Preclinical data shows that BriaCell’s Bria-OTS+™ and Bria-PROS+™ effectively induce an anti-cancer immune response via multiple mechanisms including naïve helper and killer T cells, dendritic cells, and natural killer (NK) cells The novel mechanisms of actio...
PFS of 4.2 months in Phase 2 ADC resistant patients receiving Bria-IMT™ pivotal Phase 3 formulation is twice that of controls in similar studies PFS results reinforced by larger number of prior treatments in Bria-IMT™ population than in comparable studies Bri...